Cellebrite CEO Hogan sells 103,000 shares to cover RSU tax bill
Cellebrite CEO Thomas Hogan liquidated $1.6 million in shares to satisfy tax obligations tied to restricted stock units, a routine non-discretionary move that leaves his core stake intact despite a sluggish share price.
Thomas E. Hogan sold approximately 103,000 shares of Cellebrite DI Ltd. on July 2, 2026, according to an SEC Form 4 filing. The disposal generated roughly $1.6 million at a weighted average price of $15.76 per share.
The transaction was strictly non-discretionary. Hogan executed the sale solely to cover tax liabilities triggered by the vesting of restricted stock units originally granted on Sept. 19, 2025. For market professionals, tax-motivated sales typically carry less weight than discretionary liquidations, which executives use to express bearish convictions.
Hogan retains a direct holding of 590,777 shares following the sale. This represents a 0.24% ownership stake in the digital intelligence provider. Maintaining the vast majority of his post-vesting position signals continued alignment with shareholder interests.
The sale occurred against a backdrop of modest stock performance. Cellebrite shares have delivered a 3% total return over the trailing 12 months, closing at $15.65 on July 2. The company currently commands a $4.1 billion market capitalization, supported by trailing 12-month revenue of $496.4 million and net income of $71.9 million.
The Petah Tikva-based firm provides a software-as-a-service platform used by law enforcement and government agencies for digital forensics. Its specialized, mission-critical focus translates to robust profitability, with a net profit margin of approximately 14.5% over the past year. This operational efficiency underpins the current valuation despite the flat stock trajectory.
Investors evaluating insider activity at Cellebrite will likely view this filing as administrative housekeeping rather than a fundamental red flag. The real focus for the market remains whether the company can convert its strong margins and revenue base into accelerated share price growth.
